The development and psychometric evaluation of FABIANA-checklist: a scale to assess factors influencing treatment initiation in anorexia nervosa.
Anorexia nervosa
Construct validity
Duration of untreated illness
Early intervention
Facilitators and barriers
Psychometrics
Psychotherapy
Journal
Journal of eating disorders
ISSN: 2050-2974
Titre abrégé: J Eat Disord
Pays: England
ID NLM: 101610672
Informations de publication
Date de publication:
03 Nov 2021
03 Nov 2021
Historique:
received:
27
04
2021
accepted:
03
10
2021
entrez:
4
11
2021
pubmed:
5
11
2021
medline:
5
11
2021
Statut:
epublish
Résumé
A long duration of untreated illness (DUI) is an unfavorable prognostic factor in anorexia nervosa (AN) and is associated with chronic illness progression. Although previous preventive measures aimed at reducing DUI and thus improving short- and long-term treatment outcomes have been partially successful, a better understanding of the factors involved in the sensitive phase prior to treatment initiation is needed. To date, there is no validated instrument available to assess these factors specifically for patients with AN. The FABIANA-project (Facilitators and barriers in anorexia nervosa treatment initiation) aims at identifying predictors of the DUI in order to target preventive measures better in the future. As part of this project, the FABIANA-checklist was developed, based on a multi-informant perspective and a multimodal bottom-up approach. The present study focusses on the process of item generation, item selection and psychometric validation of the checklist. Based upon a previous qualitative study, an initial set of 73 items was generated for the most frequently mentioned facilitators and barriers of treatment initiation in AN. After a process of consensual rating and cognitive pre-testing, the resulting 25-item version of the FABIANA-checklist was provided to a sample of female patients (N = 75), aged ≥ 14 years with AN that underwent their first psychotherapeutic treatment in the last 12 months. After item analysis, dimensionality of the final version of the FABIANA-checklist was tested by Principal Component Analysis (PCA). We evaluated construct validity assuming correlations with related constructs, such as perceived social support (F-SozU), support in the health care system (PACIC-5A), illness perception and coping (BIPQ). We included 54 adult and 21 adolescent patients with AN, aged on average 21.4 years. Average BMI was 15.5 kg/m The FABIANA-checklist is a valid instrument to assess factors involved in the process of treatment initiation of patients with AN. Psychometrics and dimensionality testing suggests that experienced emotional and practical support from the primary health care system and close relatives are main components. The results indicate that a differentiated assessment at item level is appropriate. In order to quantify the relative importance of the factors and to derive recommendations on early-intervention approaches, the predictive effect of the FABIANA-items on the DUI will be determined in a subsequent study which will further include the perspective of relatives and primary caregivers. Trial registration Clinical Trials.gov Identifier: NCT03713541: https://clinicaltrials.gov/ct2/show/NCT03713541 . Early treatment contributes to a more favorable illness course and an improved prognosis in patients with anorexia nervosa (AN). The current study presents the development of the FABIANA checklist, which aims to assess factors which influence duration of untreated illness. The FABIANA checklist was developed on the basis of interviews with patients, their relatives and primary care practitioners. It provides data from the first use of the checklist in a German sample of 75 patients with AN. The results of our study suggest that the FABIANA-checklist is a valid instrument to assess factors involved in the process of treatment initiation. Emotional and practical support from the primary health care system and close relatives were the most consistent components. A follow-up study will investigate the relationship between the FABIANA-items and the DUI in order to guide the conception of effective secondary prevention measures.
Sections du résumé
BACKGROUND
BACKGROUND
A long duration of untreated illness (DUI) is an unfavorable prognostic factor in anorexia nervosa (AN) and is associated with chronic illness progression. Although previous preventive measures aimed at reducing DUI and thus improving short- and long-term treatment outcomes have been partially successful, a better understanding of the factors involved in the sensitive phase prior to treatment initiation is needed. To date, there is no validated instrument available to assess these factors specifically for patients with AN. The FABIANA-project (Facilitators and barriers in anorexia nervosa treatment initiation) aims at identifying predictors of the DUI in order to target preventive measures better in the future. As part of this project, the FABIANA-checklist was developed, based on a multi-informant perspective and a multimodal bottom-up approach. The present study focusses on the process of item generation, item selection and psychometric validation of the checklist.
METHODS
METHODS
Based upon a previous qualitative study, an initial set of 73 items was generated for the most frequently mentioned facilitators and barriers of treatment initiation in AN. After a process of consensual rating and cognitive pre-testing, the resulting 25-item version of the FABIANA-checklist was provided to a sample of female patients (N = 75), aged ≥ 14 years with AN that underwent their first psychotherapeutic treatment in the last 12 months. After item analysis, dimensionality of the final version of the FABIANA-checklist was tested by Principal Component Analysis (PCA). We evaluated construct validity assuming correlations with related constructs, such as perceived social support (F-SozU), support in the health care system (PACIC-5A), illness perception and coping (BIPQ).
RESULTS
RESULTS
We included 54 adult and 21 adolescent patients with AN, aged on average 21.4 years. Average BMI was 15.5 kg/m
CONCLUSIONS
CONCLUSIONS
The FABIANA-checklist is a valid instrument to assess factors involved in the process of treatment initiation of patients with AN. Psychometrics and dimensionality testing suggests that experienced emotional and practical support from the primary health care system and close relatives are main components. The results indicate that a differentiated assessment at item level is appropriate. In order to quantify the relative importance of the factors and to derive recommendations on early-intervention approaches, the predictive effect of the FABIANA-items on the DUI will be determined in a subsequent study which will further include the perspective of relatives and primary caregivers. Trial registration Clinical Trials.gov Identifier: NCT03713541: https://clinicaltrials.gov/ct2/show/NCT03713541 .
Early treatment contributes to a more favorable illness course and an improved prognosis in patients with anorexia nervosa (AN). The current study presents the development of the FABIANA checklist, which aims to assess factors which influence duration of untreated illness. The FABIANA checklist was developed on the basis of interviews with patients, their relatives and primary care practitioners. It provides data from the first use of the checklist in a German sample of 75 patients with AN. The results of our study suggest that the FABIANA-checklist is a valid instrument to assess factors involved in the process of treatment initiation. Emotional and practical support from the primary health care system and close relatives were the most consistent components. A follow-up study will investigate the relationship between the FABIANA-items and the DUI in order to guide the conception of effective secondary prevention measures.
Autres résumés
Type: plain-language-summary
(eng)
Early treatment contributes to a more favorable illness course and an improved prognosis in patients with anorexia nervosa (AN). The current study presents the development of the FABIANA checklist, which aims to assess factors which influence duration of untreated illness. The FABIANA checklist was developed on the basis of interviews with patients, their relatives and primary care practitioners. It provides data from the first use of the checklist in a German sample of 75 patients with AN. The results of our study suggest that the FABIANA-checklist is a valid instrument to assess factors involved in the process of treatment initiation. Emotional and practical support from the primary health care system and close relatives were the most consistent components. A follow-up study will investigate the relationship between the FABIANA-items and the DUI in order to guide the conception of effective secondary prevention measures.
Identifiants
pubmed: 34732246
doi: 10.1186/s40337-021-00490-w
pii: 10.1186/s40337-021-00490-w
pmc: PMC8565008
doi:
Banques de données
ClinicalTrials.gov
['NCT03713541']
Types de publication
Journal Article
Langues
eng
Pagination
144Informations de copyright
© 2021. The Author(s).
Références
Int J Eat Disord. 2020 Jun;53(6):894-906
pubmed: 32239776
J Clin Psychol. 2010 Apr;66(4):394-409
pubmed: 20127795
Med Care Res Rev. 2006 Apr;63(2):217-35
pubmed: 16595412
Int J Eat Disord. 2012 Dec;45(8):949-56
pubmed: 23034735
Child Psychiatry Hum Dev. 2008 Sep;39(3):261-72
pubmed: 17987378
Eat Disord. 2018 May-Jun;26(3):213-228
pubmed: 29210607
Soc Psychiatry Psychiatr Epidemiol. 2016 Mar;51(3):369-81
pubmed: 26631229
Int J Eat Disord. 2006 Mar;39(2):154-61
pubmed: 16252278
Int J Eat Disord. 2019 Jun;52(6):681-690
pubmed: 30912189
Z Kinder Jugendpsychiatr Psychother. 2017 Sep;45(5):393-400
pubmed: 28825513
J Eval Clin Pract. 2007 Oct;13(5):806-13
pubmed: 17824876
Front Psychol. 2018 Nov 15;9:2145
pubmed: 30498463
Eat Disord. 2012;20(1):1-13
pubmed: 22188056
Eat Weight Disord. 2017 Sep;22(3):499-507
pubmed: 27659175
Int J Eat Disord. 2020 Aug;53(8):1337-1348
pubmed: 32064663
Psychiatry Res. 2018 Jan;259:68-76
pubmed: 29031166
Int J Eat Disord. 2009 Jul;42(5):453-8
pubmed: 19115367
J Eat Disord. 2021 Feb 27;9(1):28
pubmed: 33640028
Prim Health Care Res Dev. 2018 Jan;19(1):42-52
pubmed: 28829284
Psychiatr Prax. 2019 Sep;46(6):342-348
pubmed: 31284318
Int J Eat Disord. 2017 Jan;50(1):9-21
pubmed: 27526643
Early Interv Psychiatry. 2018 Apr;12(2):250-257
pubmed: 27619198
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78
pubmed: 11816692
J Eat Disord. 2016 May 18;4:19
pubmed: 27195123
Eur Eat Disord Rev. 2021 May;29(3):329-345
pubmed: 32578311
Eur Eat Disord Rev. 2014 Jul;22(4):292-8
pubmed: 24888519
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
Eat Disord. 2017 Jan-Feb;25(1):1-21
pubmed: 27485375
BJPsych Open. 2019 Oct 21;5(6):e92
pubmed: 31631825
Int J Eat Disord. 2017 Sep;50(9):1018-1030
pubmed: 28644530
Early Interv Psychiatry. 2020 Oct;14(5):625-630
pubmed: 32064736
Lancet Psychiatry. 2015 Dec;2(12):1099-111
pubmed: 26514083
Int J Eat Disord. 2017 Mar;50(3):190-209
pubmed: 28134980
J Psychiatr Ment Health Nurs. 2021 Apr;28(2):237-250
pubmed: 32608115
Psychiatr Prax. 2015 Jul;42 Suppl 1:S30-4
pubmed: 26135276
Eur Eat Disord Rev. 2019 May;27(3):274-282
pubmed: 30848056
Lancet. 2014 Jan 11;383(9912):127-37
pubmed: 24131861
Int J Eat Disord. 2020 Jan;53(1):61-68
pubmed: 31591750
Eur Eat Disord Rev. 2021 May;29(3):458-471
pubmed: 33112472
Eur Eat Disord Rev. 2012 Sep;20(5):343-9
pubmed: 22492553
Eat Weight Disord. 2016 Sep;21(3):365-381
pubmed: 27043947
BMC Psychiatry. 2014 Nov 18;14:300
pubmed: 25404427
Int J Eat Disord. 2017 Jul;50(7):826-833
pubmed: 28323350
Lancet Psychiatry. 2016 Apr;3(4):313-5
pubmed: 27063378
Health Expect. 2009 Dec;12(4):417-29
pubmed: 19709315
Am J Psychiatry. 2002 Aug;159(8):1284-93
pubmed: 12153817
Clin Psychol Rev. 2011 Jul;31(5):727-35
pubmed: 21501580